Abstract
We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases.
| Original language | English |
|---|---|
| Pages (from-to) | 90-92 |
| Number of pages | 3 |
| Journal | Clinical Neurology and Neurosurgery |
| Volume | 172 |
| DOIs | |
| Publication status | Published - 09-2018 |
All Science Journal Classification (ASJC) codes
- Surgery
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver